PathAI
AI-powered technology platform improving accuracy and efficiency in pathology diagnosis and drug development research.
About
PathAI develops AI-powered pathology solutions to improve patient outcomes and advance drug and diagnostic development. Their core offerings include the AISight® Digital Pathology Platform, an enterprise workflow solution for image and case management, and AI product solutions for biomarker quantification and workflow optimization. PathAI serves biopharma companies, academic medical centers, reference laboratories, and health systems. Teams look it up for AI, Healthcare, Biotech.
Frequently asked
What does PathAI do?
PathAI is an AI company that offers Platform. Teams look it up for Healthcare, Biotech, SaaS. It is based in Boston, United States and was founded in 2016. Public records show $165M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has PathAI raised?
PathAI has raised a total of $165M in funding. The most recent round on record is Series C.
Where is PathAI headquartered?
PathAI is headquartered in Boston, United States.
When was PathAI founded?
PathAI was founded in 2016.
What industry does PathAI operate in?
PathAI operates in AI, Healthcare, Biotech, SaaS, Healthcare AI.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.